Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Siyuan Gao, Mei Zhang, Kaishan Wu, Jianhong Zhu, Zhichao He, Jianfang Li, Chuxiong Chen, Kaifeng Qiu, Xiaoxia Yu & Junyan Wu. (2020) Risk of adverse events in lymphoma patients treated with brentuximab vedotin: a systematic review and meta-analysis. Expert Opinion on Drug Safety 19:5, pages 617-623.
Read now
Read now
Rudolph M Navari. (2019) The safety of rolapitant for the treatment of nausea and vomiting associated with chemotherapy. Expert Opinion on Drug Safety 18:12, pages 1127-1132.
Read now
Read now
Rudolph M Navari & Lee S Schwartzberg. (2018) Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting. OncoTargets and Therapy 11, pages 6459-6478.
Read now
Read now
Anastasia Spartinou, Vasileia Nyktari & Alexandra Papaioannou. (2017) Granisetron: a review of pharmacokinetics and clinical experience in chemotherapy induced - nausea and vomiting. Expert Opinion on Drug Metabolism & Toxicology 13:12, pages 1289-1297.
Read now
Read now
Bernardo Leon Rapoport, Matti Aapro, Martin R Chasen, Karin Jordan, Rudolph M Navari, Ian Schnadig & Lee Schwartzberg. (2017) Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populations. Drug Design, Development and Therapy 11, pages 2621-2629.
Read now
Read now
Bernardo Leon Rapoport. (2017) Differential pharmacology and clinical utility of rolapitant in chemotherapy-induced nausea and vomiting. Cancer Management and Research 9, pages 41-50.
Read now
Read now
Bernardo Rapoport & Teresa Smit. (2017) Clinical pharmacology of neurokinin-1 receptor antagonists for the treatment of nausea and vomiting associated with chemotherapy. Expert Opinion on Drug Safety 16:6, pages 697-710.
Read now
Read now
Bernardo Rapoport, Ronwyn van Eeden & Teresa Smit. (2017) Rolapitant for the prevention of delayed nausea and vomiting over initial and repeat courses of emetogenic chemotherapy. Expert Review of Clinical Pharmacology 10:1, pages 17-29.
Read now
Read now
Articles from other publishers (17)
Yunjing He, Jingrui Zheng, Binbin Ye, Yongzhao Dai & Ke Nie. (2023) Chemotherapy-induced gastrointestinal toxicity: Pathogenesis and current management. Biochemical Pharmacology 216, pages 115787.
Crossref
Crossref
Toshinobu Hayashi, Mototsugu Shimokawa, Koichi Matsuo, Masanobu Uchiyama, Kei Kawada, Takafumi Nakano & Takashi Egawa. (2023) Effectiveness of Palonosetron, 1-Day Dexamethasone, and Aprepitant in Patients Undergoing Carboplatin-Based Chemotherapy. Oncology, pages 1-7.
Crossref
Crossref
Hakan Nazlı, Burcu Mesut, Özlem Akbal-Dağıstan & Yıldız Özsoy. (2023) A Novel Semi-Solid Self-Emulsifying Formulation of Aprepitant for Oral Delivery: An In Vitro Evaluation. Pharmaceutics 15:5, pages 1509.
Crossref
Crossref
Jihee Choi, Jounghee Lee, Kijoon Kim, Hyo-Kyoung Choi, Se-A Lee & Hae-Jeung Lee. (2022) Effects of Ginger Intake on Chemotherapy-Induced Nausea and Vomiting: A Systematic Review of Randomized Clinical Trials. Nutrients 14:23, pages 4982.
Crossref
Crossref
Manik Chatterjee, Anja Gesierich, Matthias Kroiß & Volker Kunzmann. 2022. Medikamentöse Tumortherapie von Kopf-Hals-Tumoren. Medikamentöse Tumortherapie von Kopf-Hals-Tumoren
121
146
.
Tingting QiuPeng Men, Xiaohan Xu, Suodi Zhai & Xiangli Cui. (2020) Antiemetic regimen with aprepitant in the prevention of chemotherapy-induced nausea and vomiting. Medicine 99:33, pages e21559.
Crossref
Crossref
Didem Ondaş Aybar, Serap Parlar Kılıc & Havva Yeşil Çınkır. (2020) The effect of breathing exercise on nausea, vomiting and functional status in breast cancer patients undergoing chemotherapy. Complementary Therapies in Clinical Practice 40, pages 101213.
Crossref
Crossref
Lee Schwartzberg, Rudolph Navari, Rebecca Clark-Snow, Ekaterine Arkania, Irena Radyukova, Kamal Patel, Daniel Voisin, Giada Rizzi, Rita Wickham, Richard J. Gralla, Matti Aapro & Eric Roeland. (2020) Phase IIIb Safety and Efficacy of Intravenous NEPA for Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients with Breast Cancer Receiving Initial and Repeat Cycles of Anthracycline and Cyclophosphamide (AC) Chemotherapy. The Oncologist 25:3, pages e589-e597.
Crossref
Crossref
Matti Aapro, Li Zhang, Sriram Yennu, Thomas W LeBlanc & Lee Schwartzberg. (2019) Preventing chemotherapy-induced nausea and vomiting with netupitant/palonosetron, the first fixed combination antiemetic: current and future perspective. Future Oncology 15:10, pages 1067-1084.
Crossref
Crossref
Akihiko Osaki, Kenichi Inoue, Hiroshi Sakai, Kazuhiko Yamada, Koichi Minato, Fumiyoshi Ohyanagi, Yutaka Tokuda, Norihiko Ikeda, Hiroshi Kagamu, Kaoru Kubota, Tomohide Tamura & Toshiaki Saeki. (2019) A dose-finding randomized Phase II study of oral netupitant in combination with palonosetron .75 mg intravenous for the prevention of chemotherapy-induced nausea and vomiting in Japanese patients receiving highly emetogenic chemotherapy. Japanese Journal of Clinical Oncology 49:2, pages 121-129.
Crossref
Crossref
Rudolph M Navari. (2019) HTX-019: polysorbate 80- and synthetic surfactant-free neurokinin 1 receptor antagonist for chemotherapy-induced nausea and vomiting prophylaxis. Future Oncology 15:3, pages 241-255.
Crossref
Crossref
Marie-Luce Rosseels, Renaud Fleurance & Susan M.G. Goody. 2019. Advanced Issue Resolution in Safety Pharmacology. Advanced Issue Resolution in Safety Pharmacology
77
101
.
Weixia Zhong & Nissar A. Darmani. 2018. Calcium and Signal Transduction. Calcium and Signal Transduction.
Rudolph M. Navari, Bernardo L. Rapoport, Dan Powers, Sujata Arora & Rebecca Clark‐Snow. (2018) Rolapitant for the prevention of nausea in patients receiving highly or moderately emetogenic chemotherapy. Cancer Medicine 7:7, pages 2943-2950.
Crossref
Crossref
Renzo Carletti, Stefano Tacconi, Manolo Mugnaini & Philip Gerrard. (2017) Receptor distribution studies. Current Opinion in Pharmacology 35, pages 94-100.
Crossref
Crossref
Bernardo L. Rapoport. (2017) Delayed Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Incidence, and Current Management. Frontiers in Pharmacology 08.
Crossref
Crossref
Weixia Zhong, Andrew J. Picca, Albert S. Lee & Nissar A. Darmani. (2017) Ca2+ signaling and emesis: Recent progress and new perspectives. Autonomic Neuroscience 202, pages 18-27.
Crossref
Crossref